These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 21150566)

  • 21. Application of fecal hemoglobin-haptoglobin complex testing for small bowel lesions.
    Shiotani A; Tarumi K; Honda K; Fujita M; Matsumoto H; Manabe N; Kamada T; Hata J; Haruma K
    Scand J Gastroenterol; 2014 May; 49(5):539-44. PubMed ID: 24621414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Detection of protein p53 in the stool of patients with colorectal cancer].
    Jaïs P; Kapel N; Chosidow D; Rupaire N; Rougier P; Lasser P; Mignon M; Lewin MJ; Gobert JG
    Gastroenterol Clin Biol; 1997; 21(10):754-9. PubMed ID: 9587516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new approach to fecal occult blood testing based on the detection of haptoglobin.
    Xing PX; Young GP; Ho D; Sinatra MA; Hoj PB; McKenzie IF
    Cancer; 1996 Jul; 78(1):48-56. PubMed ID: 8646726
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Automatically Analyzed (AA) ColonView (CV) Quick Test for Fecal Occult Blood Shows Higher Diagnostic Accuracy in Detection of Colorectal Adenoma than Visually Analyzed Tests.
    Meklin J; Eskelinen M; Guimaraes DP; Selander T; Tiusanen T; Syrjänen K; Eskelinen M
    Anticancer Res; 2021 Nov; 41(11):5517-5525. PubMed ID: 34732422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cumulative evaluation of a quantitative immunochemical fecal occult blood test to determine its optimal clinical use.
    Rozen P; Comaneshter D; Levi Z; Hazazi R; Vilkin A; Maoz E; Birkenfeld S; Niv Y
    Cancer; 2010 May; 116(9):2115-25. PubMed ID: 20186820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonmedical costs of colorectal cancer screening with the fecal occult blood test and colonoscopy.
    Heitman SJ; Au F; Manns BJ; McGregor SE; Hilsden RJ
    Clin Gastroenterol Hepatol; 2008 Aug; 6(8):912-917.e1. PubMed ID: 18534918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of colorectal neoplasms by the highly sensitive hemoglobin-haptoglobin complex in feces.
    Sieg A; Thoms C; Lüthgens K; John MR; Schmidt-Gayk H
    Int J Colorectal Dis; 1999 Dec; 14(6):267-71. PubMed ID: 10663892
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gastrointestinal tract cancer screening using fecal carcinoembryonic antigen.
    Kim Y; Lee S; Park S; Jeon H; Lee W; Kim JK; Cho M; Kim M; Lim J; Kang CS; Han K
    Ann Clin Lab Sci; 2003; 33(1):32-8. PubMed ID: 12661896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fecal calprotectin levels predict colorectal inflammation among patients with chronic diarrhea referred for colonoscopy.
    Limburg PJ; Ahlquist DA; Sandborn WJ; Mahoney DW; Devens ME; Harrington JJ; Zinsmeister AR
    Am J Gastroenterol; 2000 Oct; 95(10):2831-7. PubMed ID: 11051356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mass spectrometry study of hemoglobin-oxaliplatin complexes in colorectal cancer patients and potential association with chemotherapeutic responses.
    Mandal R; Sawyer MB; Li XF
    Rapid Commun Mass Spectrom; 2006; 20(17):2533-8. PubMed ID: 16878345
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved fecal DNA test for colorectal cancer screening.
    Itzkowitz SH; Jandorf L; Brand R; Rabeneck L; Schroy PC; Sontag S; Johnson D; Skoletsky J; Durkee K; Markowitz S; Shuber A
    Clin Gastroenterol Hepatol; 2007 Jan; 5(1):111-7. PubMed ID: 17161655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fecal lysozyme: an unreliable marker for colorectal cancer.
    Dubrow R; Kim CS; Eldred AK
    Am J Gastroenterol; 1992 May; 87(5):617-21. PubMed ID: 1595650
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stool test for colorectal cancer screening--it's time to move!
    Loitsch SM; Shastri Y; Stein J
    Clin Lab; 2008; 54(11-12):473-84. PubMed ID: 19216253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Measurement of fecal pyruvate kinase type M2 (tumor M2-PK) concentrations in patients with gastric cancer, colorectal cancer, colorectal adenomas and controls.
    Hardt PD; Toepler M; Ngoumou B; Rupp J; Kloer HU
    Anticancer Res; 2003; 23(2A):851-3. PubMed ID: 12820312
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low faecal haemoglobin concentration potentially rules out significant colorectal disease.
    McDonald PJ; Digby J; Innes C; Strachan JA; Carey FA; Steele RJ; Fraser CG
    Colorectal Dis; 2013 Mar; 15(3):e151-9. PubMed ID: 23199241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparison of different stool tests for the detection of cancer of the colon].
    Vogel T; Driemel C; Hauser A; Hansmann A; Lange S; Jonas M; Möslein G
    Dtsch Med Wochenschr; 2005 Apr; 130(14):872-7. PubMed ID: 15800820
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population.
    Imperiale TF; Ransohoff DF; Itzkowitz SH; Turnbull BA; Ross ME;
    N Engl J Med; 2004 Dec; 351(26):2704-14. PubMed ID: 15616205
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitation of DNA from exfoliated colonocytes isolated from human stool surface as a novel noninvasive screening test for colorectal cancer.
    Loktionov A; O'Neill IK; Silvester KR; Cummings JH; Middleton SJ; Miller R
    Clin Cancer Res; 1998 Feb; 4(2):337-42. PubMed ID: 9516920
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Postoperative follow-up of patients with colorectal cancer: a combined evaluation of CT scan, colonoscopy and tumour markers.
    Ntinas A; Zambas N; Al Mogrambi S; Petras P; Chalvatzoulis E; Frangandreas G; Tsantilas D; Spiridis C; Gerasimidis T
    Tech Coloproctol; 2004 Nov; 8 Suppl 1():s190-2. PubMed ID: 15655619
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effects of exocorpol and haptoglobin on hemolysis during ECC].
    Nagamine S; Sekino Y; Tabayashi K; Haneda K; Suzuki Y; Mohri H
    Rinsho Kyobu Geka; 1989 Aug; 9(4):381-4. PubMed ID: 9301946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.